DiaMedica Therapeutics Inc.
Cash Flow Statement
| Line Item | FY2017 |
|---|---|
| Operating Activities | |
| Net Income | $-4.3M |
| Depreciation & Amortization | — |
| Depreciation | $4.0K |
| Amortization | — |
| Stock-Based Compensation | $409.0K |
| Net Cash from Operating Activities | $-3.9M |
| Investing Activities | |
| Capital Expenditures | $22.0K |
| Business Acquisitions | — |
| Net Cash from Investing Activities | $-22.0K |
| Financing Activities | |
| Dividends Paid | — |
| Stock Repurchases | — |
| Net Cash from Financing Activities | $3.5M |
| Net Change in Cash | $-383.0K |
| Free Cash Flow | $-3.9M |